Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |